Stay updated with breaking news from Mark Bleackley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) chief scientific officer Dr Mark Bleackley tells Proactive the company has completed a constructive...
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) has completed a constructive pre-Investigational New Drug (IND) application meeting with the US Food and Drug...
Public Announcement Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis ...
Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) is preparing to advance its clinical trial assessing the treatment of rheumatoid arthritis to the second...
Date: July 13, 2023 Public Announcement Incannex Receives HREC Approval for Phase...